AbbVie Inc.

108.41+0.6700+0.62%Vol 4.63M1Y Perf 26.62%
Mar 1st, 2021 16:03 DELAYED
BID108.16 ASK108.99
Open108.53 Previous Close107.74
Pre-Market- After-Market108.20
 - -  -0.21 -0.19%
Target Price
116.73 
Analyst Rating
Moderate Buy 1.64
Potential %
7.67 
Finscreener Ranking
★+     44.45
Insiders Trans % 3/6/12 mo.
-100/-100/-52 
Value Ranking
★+     45.06
Insiders Value % 3/6/12 mo.
-100/-100/-98 
Growth Ranking
★★     45.24
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-97 
Income Ranking
★★★     45.40
Market Cap191.44B 
Earnings Rating
Sell
Price Range Ratio 52W %
90.17 
Earnings Date
3rd Feb 2021

Today's Price Range

108.07109.21

52W Range

62.55113.41

5 Year PE Ratio Range

11.9038.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
2.01%
1 Month
4.77%
3 Months
3.26%
6 Months
16.96%
1 Year
26.62%
3 Years
-5.76%
5 Years
94.63%
10 Years
-

TickerPriceChg.Chg.%
ABBV108.410.67000.62
AAPL127.796.53005.39
GOOG2 081.5144.65002.19
MSFT236.944.56001.96
XOM56.402.03003.73
WFC37.090.92002.54
JNJ159.320.86000.54
FB264.917.29002.83
GE13.110.57004.55
JPM150.503.33002.26
Financial StrengthValueIndustryS&P 500US Markets
0.60
0.80
0.86
6.58
2.40
Leverage Ratio 15.50
ProfitabilityValueIndustryS&P 500US Markets
66.40
12.80
26.90
17.70
10.22
RevenueValueIndustryS&P 500US Markets
45.80B
25.94
15.82
13.41
DividendsValueIndustryS&P 500US Markets
4.80
5.20
22.28
20.31
Payout ratio98.00
Earnings HistoryEstimateReportedSurprise %
Q04 20202.852.922.46
Q03 20202.752.832.91
Q02 20202.242.344.46
Q01 20202.272.426.61
Q04 20192.202.210.45
Q03 20192.292.331.75
Q02 20192.212.262.26
Q01 20192.062.143.88
Earnings Per EndEstimateRevision %Trend
3/2021 QR2.76-2.13Negative
6/2021 QR3.098.80Positive
12/2021 FY12.462.98Positive
12/2022 FY13.772.91Positive
Next Report Date-
Estimated EPS Next Report2.85
Estimates Count6
EPS Growth Next 5 Years %4.80
Volume Overview
Volume4.63M
Shares Outstanding1.77B
Trades Count54.85K
Dollar Volume911.93M
Avg. Volume7.53M
Avg. Weekly Volume6.67M
Avg. Monthly Volume7.28M
Avg. Quarterly Volume7.15M

AbbVie Inc. (NYSE: ABBV) stock closed at 108.41 per share at the end of the most recent trading day (a 0.62% change compared to the prior day closing price) with a volume of 4.71M shares and market capitalization of 191.44B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 30000 people. AbbVie Inc. CEO is Richard A. Gonzalez.

The one-year performance of AbbVie Inc. stock is 26.62%, while year-to-date (YTD) performance is 1.18%. ABBV stock has a five-year performance of 94.63%. Its 52-week range is between 62.55 and 113.41, which gives ABBV stock a 52-week price range ratio of 90.17%

AbbVie Inc. currently has a PE ratio of 38.50, a price-to-book (PB) ratio of 14.55, a price-to-sale (PS) ratio of 4.18, a price to cashflow ratio of 10.20, a PEG ratio of 2.32, a ROA of 3.68%, a ROC of 14.01% and a ROE of 218.05%. The company’s profit margin is 10.22%, its EBITDA margin is 26.90%, and its revenue ttm is $45.80 Billion , which makes it $25.94 revenue per share.

Of the last four earnings reports from AbbVie Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.85 for the next earnings report. AbbVie Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for AbbVie Inc. is Moderate Buy (1.64), with a target price of $116.73, which is +7.67% compared to the current price. The earnings rating for AbbVie Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AbbVie Inc. has a dividend yield of 4.80% with a dividend per share of $5.20 and a payout ratio of 98.00%.

AbbVie Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 7.84, ATR14 : 3.28, CCI20 : 67.86, Chaikin Money Flow : -0.05, MACD : 0.19, Money Flow Index : 53.74, ROC : 3.55, RSI : 54.49, STOCH (14,3) : 72.97, STOCH RSI : 0.68, UO : 52.36, Williams %R : -27.03), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AbbVie Inc. in the last 12-months were: Azita Saleki-Gerhardt (Option Excercise at a value of $116 199), Azita Saleki-Gerhardt (Sold 22 226 shares of value $2 157 076 ), Brian L. Durkin (Buy at a value of $362 705), Carlos Alban (Option Excercise at a value of $4 155 980), Carlos Alban (Sold 169 155 shares of value $16 915 554 ), Edward J. Rapp (Buy at a value of $505 234), Elaine K. Sorg (Option Excercise at a value of $1 813 052), Elaine K. Sorg (Sold 20 195 shares of value $2 114 732 ), Henry O. Gosebruch (Sold 40 000 shares of value $3 975 046 ), Jeffrey Ryan Stewart (Option Excercise at a value of $2 600 822), Jeffrey Ryan Stewart (Sold 96 628 shares of value $9 455 320 ), Michael Severino (Sold 90 679 shares of value $8 488 461 ), Richard A. Gonzalez (Option Excercise at a value of $11 089 858), Richard A. Gonzalez (Sold 231 604 shares of value $22 437 252 ), Timothy J. Richmond (Option Excercise at a value of $2 673 325), Timothy J. Richmond (Sold 71 435 shares of value $7 111 775 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
9 (64.29 %)
8 (66.67 %)
6 (50.00 %)
Moderate Buy
1 (7.14 %)
1 (8.33 %)
0 (0.00 %)
Hold
4 (28.57 %)
3 (25.00 %)
6 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.64
Moderate Buy
1.58
Moderate Buy
2.00

AbbVie Inc.

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. The recent announced acquisition of Allergan will add several new drugs in aesthetics and women's health.

CEO: Richard A. Gonzalez

Teplephone: +1 847 932-7900

Address: 1 North Waukegan Road, North Chicago 60064-6400, IL, USA

Number of employees: 30 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

54%46%

Bearish Bullish

51%49%

Bearish Bullish

56%44%

News

Stocktwits